Metabolism and mechanisms of action of bendamustine: Rationales for combination therapies

被引：82

作者：

Gandhi, V ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1053/sonc.2002.34872

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4 / 11

页数：8

共 71 条

[1]

AIVADO M, 2001, P AN M AM SOC CLIN, V20, pA306

[2]

AKINAGA S, 1991, CANCER RES, V51, P4888

[3]

[Anonymous], 1971, ZBL PHARM

[4]

Balfour JAB, 2001, DRUGS, V61, P631

[5]

Bunch RT, 1996, CLIN CANCER RES, V2, P791

[6] DNA repair: Enzymatic mechanisms and relevance to drug response [J].

Chaney, SG ;

Sancar, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19) :1346-1360

[7]

Chow KU, 2001, HAEMATOLOGICA, V86, P485

[8] Repair of DNA interstrand cross-links [J].

Dronkert, MLG ;

Kanaar, R .

MUTATION RESEARCH-DNA REPAIR, 2001, 486 (04) :217-247

[9] Mechanisms of action and resistance to tubulin-binding agents [J].

Dumontet, C .

EASTMAN, A ;

SCHULTE, N .